Feeds

Men may be able to grow a new pancreas from their testicles

Dead chaps' junk used to cure diabetic mice

Application security programs and practises

Topflight geneticists say they have managed to cure diabetes in mice by grafting material from dead men's testicles onto them. The development may mean that in future, human (male) diabetes sufferers can in effect grow a replacement bollock-based pancreas from such tissues.

According to an announcement from the lab involved, headed “Grow Your Own Transplant”:

The research team took 1 gram of tissue from human testes and produced about 1 million stem cells in the laboratory. These cells showed many of the biological markers that characterize normal beta islet cells. They then transplanted those cells into the back of immune deficient diabetic mice, and were able to decrease glucose levels in the mice for about a week – demonstrating the cells were producing enough insulin to reduce hyperglycemia.

The gram of tissue came from "deceased human organ donors" in this case, but the researchers flag up the idea that in future, male diabetes sufferers would offer up such a donation while still alive, allowing docs to produce stem cells from these functioning insulin-yielding ones – so controlling the illness without the various kinds of problems that go with other methods. (For instance suitable insulin-producer cells are sometimes taken from dead donors: but there aren't nearly enough such donors to go around, and furthermore the patient's body tends to reject such alien cells – which it wouldn't do with ones grown from its own familiar cells.)

“No stem cells, adult or embryonic, have been induced to secrete enough insulin yet to cure diabetes in humans, but we know SSCs [spermatogonial stem cells] have the potential to do what we want them to do, and we know how to improve their yield,” says medi-prof G Ian Gallicano, one of the boffins who carried out the experiments.

Potentially good – if eyewatering – news down the road for male diabetes sufferers, then. And Gallicano isn't sure, but he thinks it might be possible to carry out a similar procedure using female cells equivalent to SSCs – oocytes. ®

Build a business case: developing custom apps

More from The Register

next story
Asteroid's DINO KILLING SPREE just bad luck – boffins
Sauricide WASN'T inevitable, reckon scientists
BEST BATTERY EVER: All lithium, all the time, plus a dash of carbon nano-stuff
We have found the Holy Grail (of batteries) - boffins
The Sun took a day off last week and made NO sunspots
Someone needs to get that lazy star cooking again before things get cold around here
Boffins discuss AI space program at hush-hush IARPA confab
IBM, MIT, plenty of others invited to fill Uncle Sam's spy toolchest, but where's Google?
Famous 'Dish' radio telescope to be emptied in budget crisis: CSIRO
Radio astronomy suffering to protect Square Kilometre Array
Bad back? Show some spine and stop popping paracetamol
Study finds common pain-killer doesn't reduce pain or shorten recovery
Forty-five years ago: FOOTPRINTS FOUND ON MOON
NASA won't be back any time soon, sadly
prev story

Whitepapers

Implementing global e-invoicing with guaranteed legal certainty
Explaining the role local tax compliance plays in successful supply chain management and e-business and how leading global brands are addressing this.
Consolidation: The Foundation for IT Business Transformation
In this whitepaper learn how effective consolidation of IT and business resources can enable multiple, meaningful business benefits.
Application security programs and practises
Follow a few strategies and your organization can gain the full benefits of open source and the cloud without compromising the security of your applications.
How modern custom applications can spur business growth
Learn how to create, deploy and manage custom applications without consuming or expanding the need for scarce, expensive IT resources.
Securing Web Applications Made Simple and Scalable
Learn how automated security testing can provide a simple and scalable way to protect your web applications.